title: Effects of the concomitant administration of tamsulosin (0.8 mg/day) on the pharmacokinetic and safety profile of theophylline (5 mg/kg): a placebo-controlled evaluation.
abstract: We performed a single-blind, sequential-design study to investigate the effects of concomitant oral tamsulosin 0.8 mg/day on the pharmacokinetics and safety of intravenous theophylline 5 mg/kg in healthy subjects. Ten healthy volunteers aged 19-39 years received placebo on study days 0, 1, 2 and 10 and tamsulosin on days 3-9. Theophylline was administered intravenously on days 1 and 9. Theophylline and tamsulosin pharmacokinetic data were determined following administration of the drugs on days 1 and 9 and day 9, respectively. No differences were observed in theophylline pharmacokinetic parameters with and without concomitant tamsulosin, and there were no abnormalities in tamsulosin pharmacokinetic data. Some significant changes in vital signs and a number of mild adverse reactions were reported, but the overall safety profile of tamsulosin and theophylline was acceptable. The results of the study suggest that no dose adjustment in tamsulosin is necessary when it is administered concomitantly with theophylline.
authors.affiliation: Yamanouchi USA, Inc., White Plains, New York, USA. miyazawa.yasushi@yamanouchi.co.jp
authors.forename: Y
authors.initials: Y
authors.lastname: Miyazawa
authors.forename: L P
authors.initials: LP
authors.lastname: Starkey
authors.forename: A
authors.initials: A
authors.lastname: Forrest
authors.forename: J J
authors.initials: JJ
authors.lastname: Schentag
authors.forename: H
authors.initials: H
authors.lastname: Kamimura
authors.forename: H
authors.initials: H
authors.lastname: Swarz
authors.forename: Y
authors.initials: Y
authors.lastname: Ito
mesh_terms: D000284:Administration, Oral; D000317:Adrenergic alpha-Antagonists / Q000008:administration & dosage / Q000493:pharmacokinetics; D001993:Bronchodilator Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics*; D004347:Drug Interactions; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D011470:Prostatic Hyperplasia / Q000188:drug therapy; D012449:Safety; D013449:Sulfonamides / Q000008:administration & dosage* / Q000493:pharmacokinetics; D000077409:Tamsulosin; D013806:Theophylline / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics*
chemical_list: D000317:Adrenergic alpha-Antagonists; D001993:Bronchodilator Agents; D013449:Sulfonamides; D013806:Theophylline; D000077409:Tamsulosin